A million veterans gave DNA to aid health research
Data from the project has contributed to research on the genetics of anxiety and peripheral artery disease, for instance, and has resulted in hundreds of published papers. Researchers say the repository has the potential to help answer health questions not only specific to veterans — like who is most vulnerable to post-service mental health issues, or why they seem more prone to cancer — but also relevant to the nation as a whole.
'When the VA does research, it helps veterans, but it helps all Americans,' Shulkin said in an interview. Researchers now say they fear the program is in limbo, jeopardising the years of work it took to gather the veterans' genetic data and other information, like surveys and blood samples. 'There's sort of this cone of silence,' said Amy Justice, a Yale epidemiologist with a VA appointment as a staff physician. 'We've got to make sure this survives.'
Genetic data is enormously complex, and analyzing it requires vast computing power that VA doesn't possess. Instead, it has relied on a partnership with the Energy Department, which provides its supercomputers for research purposes. In late April, VA Secretary Doug Collins disclosed to Sen. Richard Blumenthal, the top Democrat on the Senate Veterans' Affairs Committee, that agreements authorising use of the computers for the genomics project remained unsigned, with some expiring in September, according to materials shared with KFF Health News by congressional Democrats.
Spokespeople for the two agencies did not reply to multiple requests for comment. Other current and former employees within the agencies — who asked not to be identified, for fear of reprisal from the Trump administration — said they don't know whether the critical agreements will be renewed.
One researcher called computing 'a key ingredient' to major advances in health research, such as the discovery of new drugs. The agreement with the Energy Department 'should be extended for the next 10 years,' the researcher said. The uncertainty has caused 'incremental' damage, Justice said, pointing to some Million Veteran Program grants that have lapsed. As the year progresses, she predicted, 'people are going to be feeling it a lot.' Because of their military experience, maintaining veterans' health poses different challenges compared with caring for civilians. The program's examinations of genetic and clinical data allow researchers to investigate questions that have bedeviled veterans for years. As examples, Shulkin cited 'how we might be able to better diagnose earlier and start thinking about effective treatments for these toxic exposures' — such as to burn pits used to dispose of trash at military outposts overseas — as well as predispositions to post-traumatic stress disorder. 'The rest of the research community isn't likely to focus specifically' on veterans, he said. The VA community, however, has delivered discoveries of importance to the world: Three VA researchers have won Nobel Prizes, and the agency created the first pacemaker. Its efforts also helped ignite the boom in GLP-1 weight loss drugs. Yet turbulence has been felt throughout VA's research enterprise. Like other government scientific agencies, it's been buffeted by layoffs, contract cuts, and canceled research.
'There are planned trials that have not started, there are ongoing trials that have been stopped, and there are trials that have fallen apart due to staff layoffs — yes or no?' said Sen. Patty Murray (D-Wash.), pressing Collins in a May hearing of the Senate Veterans' Affairs Committee. The agency, which has a budget of roughly $1 billion for its research arm this fiscal year, has slashed infrastructure that supports scientific inquiry, according to documents shared with KFF Health News by Senate Democrats on the Veterans' Affairs Committee. It has canceled at least 37 research-related contracts, including for genomic sequencing and for library and biostatistics services. The department has separately canceled four contracts for cancer registries for veterans, creating potential gaps in the nation's statistics.
Job worries also consume many scientists at the VA. According to agency estimates in May, about 4,000 of its workers are on term limits, with contracts that expire after certain periods. Many of these individuals worked not only for the VA's research groups but also with clinical teams or local medical centers. When the new leaders first entered the agency, they instituted a hiring freeze, current and former VA researchers told KFF Health News. That prevented the agency's research offices from renewing contracts for their scientists and support staff, which in previous years had frequently been a pro forma step.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
7 hours ago
- Khaleej Times
Coca-Cola plans US cane sugar alternative after Trump push
Coca-Cola on Tuesday said it would release a version of Coke in the United States made with US-grown real cane sugar, a move requested by President Donald Trump. "We're going to be bringing a Coke sweetened with US cane sugar into the market this fall, and I think that will be an enduring option for consumers," said CEO James Quincey on a call with analysts. The company currently uses high-fructose corn syrup (HFCS) for many of its US products — a sweetener that has long drawn criticism from Health Secretary Robert F. Kennedy Jr. and his "Make America Healthy Again" agenda. Trump last week said that the company had agreed to use cane sugar in the United States version of Coke. "This will be a very good move by them — You'll see. It's just better!" Trump wrote on Truth Social. Coca-Cola at the time did not confirm the move even if it said it appreciated Trump's "enthusiasm" for its brand. In announcing the new option, Quincey insisted that the main Coke product would still be made with corn syrup, with the cane sugar version offered as an alternative. Mexican Coke — which is made with cane sugar — is often sold at a premium in US stores and prized for its more "natural" flavour. The US president did not explain what motivated his push for the change, which would not impact his well-known favorite beverage, Diet Coke. Since his return to the White House, Trump has reinstalled a special button in the Oval Office that summons a helping of the sugar-free carbonated drink. HFCS became popular in the 1970s, with its use skyrocketing thanks to government subsidies for corn growers and high import tariffs on cane sugar. Any shift away from corn is likely to draw backlash in the Corn Belt, a Midwestern region that has been a stronghold of support for Trump. Both HFCS and sucrose (cane sugar) are composed of fructose and glucose, but differ at the structural level. Those differences don't appear to significantly affect health outcomes, according to research. Trump's preferred Diet Coke is sweetened with aspartame — a compound classified as a "possible carcinogen" by the International Agency for Research on Cancer (IARC).
Al Etihad
15 hours ago
- Al Etihad
AstraZeneca says to invest $50 billion in the US
22 July 2025 11:25 LONDON (AFP)British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.A large chunk of the funds will go toward building a multi-billion-dollar manufacturing centre in Virginia, the company said in a statement, adding that it expects 50 percent of its revenue to come from the United States by 2030."Today's announcement underpins our belief in America's innovation in biopharmaceuticals," the statement quoted CEO Pascal Soriot as President Donald Trump has opened the door to potential tariffs targeting pharmaceuticals, which have so far benefited from exemptions to his sweeping levies on imports from trading ordered an investigation launched into pharmaceutical imports, suggesting that levies could reach up to 200 United States is a key market for the pharmaceutical industry, and AstraZeneca had already announced in April that it had begun transferring part of its European production to the United States. "For decades Americans have been reliant on foreign supply of key pharmaceutical products," US Commerce Secretary Howard Lutnick said in a added that the new tariffs are focused on "ending this structural weakness."The announcement included a new factory in Virginia, which will be the company's "largest single manufacturing investment." Other major pharmaceutical companies, which had been exempt from tariffs for 30 years, have, in recent months, begun shifting investment and production to the United States.
Gulf Today
2 days ago
- Gulf Today
A million veterans gave DNA to aid health research
One of the world's biggest genetic databases comprises DNA data donated over the years by more than a million retired military service members. It's part of a project run by the Department of Veterans Affairs. The initiative, dubbed the Million Veteran Program, is a 'crown jewel of the country,' said David Shulkin, a physician who served as VA secretary during the first Trump administration. Data from the project has contributed to research on the genetics of anxiety and peripheral artery disease, for instance, and has resulted in hundreds of published papers. Researchers say the repository has the potential to help answer health questions not only specific to veterans — like who is most vulnerable to post-service mental health issues, or why they seem more prone to cancer — but also relevant to the nation as a whole. 'When the VA does research, it helps veterans, but it helps all Americans,' Shulkin said in an interview. Researchers now say they fear the program is in limbo, jeopardising the years of work it took to gather the veterans' genetic data and other information, like surveys and blood samples. 'There's sort of this cone of silence,' said Amy Justice, a Yale epidemiologist with a VA appointment as a staff physician. 'We've got to make sure this survives.' Genetic data is enormously complex, and analyzing it requires vast computing power that VA doesn't possess. Instead, it has relied on a partnership with the Energy Department, which provides its supercomputers for research purposes. In late April, VA Secretary Doug Collins disclosed to Sen. Richard Blumenthal, the top Democrat on the Senate Veterans' Affairs Committee, that agreements authorising use of the computers for the genomics project remained unsigned, with some expiring in September, according to materials shared with KFF Health News by congressional Democrats. Spokespeople for the two agencies did not reply to multiple requests for comment. Other current and former employees within the agencies — who asked not to be identified, for fear of reprisal from the Trump administration — said they don't know whether the critical agreements will be renewed. One researcher called computing 'a key ingredient' to major advances in health research, such as the discovery of new drugs. The agreement with the Energy Department 'should be extended for the next 10 years,' the researcher said. The uncertainty has caused 'incremental' damage, Justice said, pointing to some Million Veteran Program grants that have lapsed. As the year progresses, she predicted, 'people are going to be feeling it a lot.' Because of their military experience, maintaining veterans' health poses different challenges compared with caring for civilians. The program's examinations of genetic and clinical data allow researchers to investigate questions that have bedeviled veterans for years. As examples, Shulkin cited 'how we might be able to better diagnose earlier and start thinking about effective treatments for these toxic exposures' — such as to burn pits used to dispose of trash at military outposts overseas — as well as predispositions to post-traumatic stress disorder. 'The rest of the research community isn't likely to focus specifically' on veterans, he said. The VA community, however, has delivered discoveries of importance to the world: Three VA researchers have won Nobel Prizes, and the agency created the first pacemaker. Its efforts also helped ignite the boom in GLP-1 weight loss drugs. Yet turbulence has been felt throughout VA's research enterprise. Like other government scientific agencies, it's been buffeted by layoffs, contract cuts, and canceled research. 'There are planned trials that have not started, there are ongoing trials that have been stopped, and there are trials that have fallen apart due to staff layoffs — yes or no?' said Sen. Patty Murray (D-Wash.), pressing Collins in a May hearing of the Senate Veterans' Affairs Committee. The agency, which has a budget of roughly $1 billion for its research arm this fiscal year, has slashed infrastructure that supports scientific inquiry, according to documents shared with KFF Health News by Senate Democrats on the Veterans' Affairs Committee. It has canceled at least 37 research-related contracts, including for genomic sequencing and for library and biostatistics services. The department has separately canceled four contracts for cancer registries for veterans, creating potential gaps in the nation's statistics. Job worries also consume many scientists at the VA. According to agency estimates in May, about 4,000 of its workers are on term limits, with contracts that expire after certain periods. Many of these individuals worked not only for the VA's research groups but also with clinical teams or local medical centers. When the new leaders first entered the agency, they instituted a hiring freeze, current and former VA researchers told KFF Health News. That prevented the agency's research offices from renewing contracts for their scientists and support staff, which in previous years had frequently been a pro forma step.
